Lower CYP2C9 activity in Turkish patients with Behçet's disease compared to healthy subjects: a down-regulation due to inflammation?...Cytochrome P450 2C9
Background: We previously reported on a Swedish patient with Behçet's disease (BD) who was an ultra-rapid metaboliser of drugs catalysed by CYP2C9. Was this extreme metabolism caused by the disease? Aim: This study aims to compare the genotype/phenotype of CYP2C9 in patients with BD and healthy subj...
| Published in: | European Journal of Clinical Pharmacology Vol. 71; no. 10; pp. 1223 - 1229 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | research tables/charts Journal Article |
| Published: |
Springer Nature
Oct2015
|
| Online Access: | View this record in EBSCOhost |